Systems and methods for plant genome editing using Cas 12a orthologs
A non-naturally occurring heterologous CRISPR-Cas12a genomic editing system is described, including or encoding at least one Cas12a ortholog endonuclease selected from among Lb5Cas12a, CMaCas12a, BsCas12a, BoCas12a, MlCas12a, Mb2Cas12a, MbCas12a TsCas12a, and MAD7® ErCas12a endonucleases. The ortholog endonucleases enable genomic editing of plants at low temperatures, e.g., below 25° C. The CRISPR-Cas12a system can be employed for targeting PAM sites such as TTN, TTV, TTTV, NTTV, TATV, TATG, TATA, YTTN, GTTA, and GTTC, utilizing corresponding gRNAs, and is readily adapted to multiplexed editing operations of plants such as rice and other food crops.
1 . A non-naturally occurring CRISPR-Cas12a plant genomic editing system, comprising or encoding (i) an RVR variant Mb2Cas12a endonuclease comprising SEQ ID NO: 299, and (ii) at least one guide RNA (gRNA) coactive with the RVR variant Mb2Cas12a endonuclease for genomic editing of a target DNA binding the gRNA, wherein the RVR variant Mb2Cas12a endonuclease and the at least one guide RNA (gRNA) do not naturally occur together, and wherein the CRISPR-Cas12a plant genomic editing system is in a rice plant and the RVR variant Mb2Cas12a endonuclease edits the rice plant in OsPDS, OsDEP1, and OsROC5 genes thereof at sites with TATV PAMs at editing efficiencies from 20% to 42.9%.
2 . The system of claim 1 , comprising a vector comprising the sequence of SEQ ID NO: 15.
3 . The system of claim 1 , comprising a CRISPR-Cas 12a expression system encoding the RVR variant Mb2Cas12a endonuclease and crRNAs for forming gRNAs that are coactive with the RVR variant Mb2Cas12a endonuclease.
4 . A non-naturally occurring multiplexing plant genomic editing system, comprising one or more vectors comprising at least one CRISPR RNA (crRNA) polymerase II (pol II) regulatory element operably linked to nucleotide sequences encoding CRISPR-Cas12a system crRNAs for producing gRNAs for targeting multiple target sequences, and at least one regulatory element, which may be the same as the crRNA regulatory element, or different therefrom, operably linked to at least one nucleotide sequence encoding an RVR variant Mb2Cas12a endonuclease comprising SEQ ID NO: 299, for generation of a CRISPR-Cas12a editing structure by which the gRNAs target the multiple target sequences and the RVR variant Mb2Cas 12a endonuclease cleaves target DNA to alter gene expression in the cell, wherein the RVR variant Mb2Cas 12a endonuclease, and the gRNAs, do not naturally occur together, and wherein the CRISPR-Cas12a plant genomic editing system is in a rice plant in which the RVR variant Mb2Cas 12a endonuclease targets multiple genes including OsPDS, OsDEP1, and OsROC5 in the rice plant at PAM sites including TTV, TTTV, and TATV.
5 . The system of claim 1 , comprising a STU regulatory element that is operably linked to a nucleotide sequence encoding a CRISPR-Cas12a system crRNA and to a nucleotide sequence encoding the RVR variant Mb2Cas12a endonuclease.
6 . The system of claim 5 , wherein the STU regulatory element comprises a RNA polymerase II (Pol II) promoter.
7 . The system of claim 1 , comprising one or more crRNA regulatory elements operably linked to respective multiple nucleotide sequences encoding respective ones of multiple CRISPR-Cas12a system crRNAs, for targeting multiple target sequences, for multiplexed genomic editing by the RVR variant Mb2Cas12a endonuclease.
8 . The system of claim 1 , comprising a nucleotide sequence encoding the RVR variant Mb2Cas12a endonuclease, a nucleotide sequence encoding a crRNA for forming a gRNA for the RVR variant Mb2Cas12a endonuclease, and multiple ones of a same promoter, wherein one of the multiple ones of the same promoter is operably linked with the nucleotide sequence encoding the RVR variant Mb2Cas12a endonuclease, and another one of the multiple ones of the same promoter is operably linked with the nucleotide sequence encoding the crRNA for forming the gRNA for the RVR variant Mb2Cas12a endonuclease, with the same promoter being effective to produce expression in both nucleotide sequences.
9 . The system of claim 1 , comprising one or more expression cassettes comprising crRNA expression-regulating regulatory elements operably linked to nucleotide sequences encoding crRNAs for forming gRNAs hybridizing to target sequences of DNA, and nuclease expression-regulating regulatory elements operably linked to nucleotide sequences encoding the RVR variant Mb2Cas12a endonuclease that is effective with the gRNAs for said genomic editing, wherein the crRNA expression-regulating regulatory elements and nuclease expression-regulating regulatory elements comprise the same or different promoters.
10 . The system of claim 1 , comprising an expression cassette in which one or more crRNA nucleotide sequences are present, wherein hammerhead (HH) and hepatitis delta virus (HDV) ribozymes flank each crRNA nucleotide sequence in a HH-crRNA-HDV arrangement.
11 . The system of claim 10 , wherein the cassette expresses the RVR variant Mb2Cas 12a endonuclease.
12 . The system of claim 1 , comprising one or more expression cassettes, comprising multiple crRNA nucleotide sequences, wherein hammerhead (HH) and hepatitis delta virus (HDV) ribozymes flank each crRNA nucleotide sequence in a HH-crRNA-HDV arrangement.
13 . The system of claim 12 , wherein the one or more expression cassettes express the RVR variant Mb2Cas12a endonuclease.
14 . The system of claim 13 , wherein expression of both the RVR variant Mb2Cas 12a endonuclease and multiple crRNAs from the multiple crRNA nucleotide sequences is operatively effected by a ZmUbi promoter.
15 . The system of claim 1 , comprising one or more expression cassettes, comprising one or more CRISPR arrays, wherein hammerhead (HH) and hepatitis delta virus (HDV) ribozymes flank each CRISPR array in a HH-CRISPR array-HDV arrangement.
16 . The system of claim 4 , wherein the system targets the PAM sites of TATC, TATG, and TATA, with editing efficiency of 20% to 42.9%.
17 . The system of claim 1 , comprising one or more crRNA nucleotide sequences operatively linked with a regulatory element, to express one or more crRNA including a protospacer sequence at least 19 bp in length.
18 . A method of genomically editing a rice plant, comprising introducing into such rice plant a non-naturally occurring heterologous CRISPR-Cas 12a genomic editing system according to claim 1 , to cause the RVR variant Mb2Cas12a nuclease to cleave DNA in the rice plant to alter the rice plant's gene expression.
19 . The method of claim 18 , wherein the CRISPR-Cas 12a genomic editing system targets PAM sites including any one or more of TATG and TATA.
20 . The method of claim 18 , as carried out at a temperature below 25° C. and above temperature producing freezing or frost damage of the plant.
21 . The method of claim 18 , wherein the rice plant is edited at one or more of OsPDS, OsDEP1, and OsROC5.
22 . The method of claim 18 , wherein the CRISPR-Cas12a genomic editing system comprises gRNAs that are targetingly effective for multiple genomic loci in the plant, to enable multiplexed genomic editing of the plant by the RVR variant Mb2Cas12a endonuclease.
23 . A non-naturally occurring CRISPR-Cas12a plant genomic editing system, comprising or encoding (i) an RVR variant Mb2Cas12a endonuclease comprising the sequence of SEQ ID NO: 299 including the mutations N563R, K569V, and N573R, and (ii) at least one guide RNA (gRNA) coactive with the RVR variant Mb2Cas12a endonuclease for genomic editing of a target DNA binding the gRNA, wherein the RVR variant Mb2Cas12a endonuclease and the at least one guide RNA (gRNA) do not naturally occur together, and wherein the CRISPR-Cas 12a plant genomic editing system is in a rice plant and edits genes therein at sites with TATV PAMs at editing efficiency of 20% to 42.9%.